buy medicine online indiamedicine online

    Glimepiride + Metformin

    Information about Glimepiride + Metformin

    Glimepiride + metformin uses

    Glimepiride+Metformin is used in the treatment of type 2 diabetes.

    How glimepiride + metformin works

    This is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.

    Common side effects of glimepiride + metformin

    Hypoglycemia (low blood sugar level), Altered taste, Nausea, Diarrhoea, Stomach pain, Headache, Upper respiratory tract infection

    Available Medicine for Glimepiride + Metformin

    • ₹48 to ₹130
      USV Ltd
      10 variant(s)
    • ₹25 to ₹107
      Sun Pharmaceutical Industries Ltd
      10 variant(s)
    • ₹67 to ₹188
      Lupin Ltd
      14 variant(s)
    • ₹136 to ₹236
      Sanofi India Ltd
      2 variant(s)
    • ₹113 to ₹397
      Sanofi India Ltd
      8 variant(s)
    • ₹47 to ₹150
      Eris Life Sciences Pvt Ltd
      14 variant(s)
    • ₹64 to ₹167
      Torrent Pharmaceuticals Ltd
      8 variant(s)
    • ₹76 to ₹192
      Micro Labs Ltd
      3 variant(s)
    • ₹49 to ₹233
      Mankind Pharma Ltd
      8 variant(s)
    • ₹77 to ₹158
      4 variant(s)

    Expert advice for Glimepiride + Metformin

    • Glimepiride+Metformin is a combination medicine to lower blood sugar.
    • You should continue to exercise regularly and take a healthy diet.
    • You may experience an upset stomach with nausea and diarrhoea in the first two weeks. Take it with food to avoid an upset stomach.
    • Tell your doctor if you experience rapid breathing, ongoing nausea, vomiting, or stomach pain.
    • Limit alcohol consumption when taking Glimepiride+Metformin.

    Content on this page was last updated on 11 May, 2018, by Dr. Varun Gupta (MD Pharmacology)